Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the OMA1-DELE1-HRI Axis and PINK1-parkin-mediated Mitophagy in Parkinson's Disease.

CNS & neurological disorders drug targets·2026
Same author

Pharmacogenomic Profiling of Voriconazole Enables Predicting Its Toxicity in Pediatric Leukemia and Hematopoietic Stem Cell Transplant Recipients-A Prospective Study From North India.

Journal of clinical pharmacology·2026
Same author

Artificial intelligence in oncology: Current status and possibilities (Review).

Medicine international·2026
Same author

The Role of NLRP3 Inflammasomes in Neurological Disorders: Mechanistic Understanding and Phytochemical-Based Therapeutics.

Phytotherapy research : PTR·2026
Same author

The Paradigms and Paradoxes of Sigma Metrics in the Analytical Phase of the Medical Diagnostic Laboratory.

Indian journal of clinical biochemistry : IJCB·2026
Same author

Unconventional Non-rodent Models in Neurological Research: Exploring New Paths to Translational Insights.

Journal of molecular neuroscience : MN·2025
Same journal

Neuroprotective Efficacy of Silymarin against Oxidative Stress, Inflammation, and Structural Changes Mediated by Arsenic-induced Toxicity in Rats.

Indian journal of clinical biochemistry : IJCB·2026
Same journal

Validation of New Micro-spectrophotometric Method to Determine Diamine Oxidase Activity in Serum.

Indian journal of clinical biochemistry : IJCB·2026
Same journal

Attitudes of Algorithms: An Exploration of the Ethics of CRISPR Cas9 through the Lens of ChatGPT.

Indian journal of clinical biochemistry : IJCB·2026
Same journal

Pharmacometabolomic Modulation of Biomarkers and Analytical Challenges in GLP-1 Receptor Agonist Therapy.

Indian journal of clinical biochemistry : IJCB·2026
Same journal

Zerumbone Induces Apoptosis and Inhibits Migration of A2058 Melanoma stem-like Cells by Producing Reactive Oxygen Species, Causing G2/M Cell Cycle Arrest, and Controlling the Expression of Genes Linked to Metastasis.

Indian journal of clinical biochemistry : IJCB·2026
Same journal

Elevated Oxidized LDL Level is Associated with Systematic Coronary Risk Evaluation (SCORE2) High-Risk Prediction Algorithm: A Preliminary Study.

Indian journal of clinical biochemistry : IJCB·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.7K

The Hemolyzed Sample: To Analyse Or Not To Analyse.

Seema Bhargava1, Parul Singla1, Anjali Manocha1

  • 1Department of Biochemistry, Sir Ganga Ram Hospital, New Delhi-60, India.

Indian Journal of Clinical Biochemistry : IJCB
|April 1, 2020
PubMed
Summary
This summary is machine-generated.

Hemolysis significantly impacts laboratory results, causing up to 60% of preanalytical errors. This study found that BUN, creatinine, amylase, and lipase can be reliably measured in hemolyzed samples, unlike phosphorus, sodium, potassium, total protein, and LDH.

Keywords:
HemolysisMethotrexatePreanalytical errorTacrolimusTotal allowable error TEa

More Related Videos

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
11:12

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs

Published on: March 9, 2013

35.4K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

582

Related Experiment Videos

Last Updated: Dec 25, 2025

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.7K
Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
11:12

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs

Published on: March 9, 2013

35.4K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

582

Area of Science:

  • Clinical Chemistry
  • Laboratory Medicine
  • Analytical Toxicology

Background:

  • Preanalytical errors are a major source of laboratory inaccuracies, with hemolysis accounting for a substantial portion.
  • Hemolysis can lead to the misinterpretation of analyte concentrations, affecting patient diagnosis and treatment.

Purpose of the Study:

  • To quantify the interference of visible hemolysis on various laboratory analytes.
  • To determine acceptable limits for analyzing samples with different degrees of hemolysis.

Main Methods:

  • Prepared serial dilutions of hemolyzed serum with unhemolyzed serum (10%-100% hemolysis).
  • Analyzed multiple analytes including BUN, creatinine, uric acid, phosphorus, electrolytes (Na, K), total protein, enzymes (amylase, lipase, LDH), and therapeutic drugs (tacrolimus, methotrexate).
  • Calculated percentage difference against unhemolyzed samples and compared with total error acceptable criteria (TEa).

Main Results:

  • BUN, creatinine, amylase, lipase, tacrolimus, and methotrexate showed results within TEa across all tested hemolysis levels.
  • Phosphorus, sodium, potassium, total protein, and LDH exceeded TEa even at low hemolysis levels.
  • Uric acid demonstrated acceptable results only in moderately hemolyzed samples.

Conclusions:

  • Analysis of BUN, creatinine, amylase, lipase, tacrolimus, and methotrexate is generally safe in hemolyzed samples.
  • Phosphorus, sodium, potassium, total protein, and LDH should not be analyzed in hemolyzed samples.
  • Uric acid analysis may be feasible with moderate hemolysis, requiring careful consideration.